Health
Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection? – News-Medical.Net
A new study by scientists in the UK raises the very useful hypothesis that natural infection may help spread the vaccine thinner without loss of efficacy.
The end of the ongoing coronavirus disease 2019 (COVID-19) pandemic may be in sight, with several countries having rolled out vaccination programs against the causative pathogen: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These campaigns aim to induce population immunity rapidly.
A new study by scientists in the UK raises the very useful hypothesis that natural infection may help spread the vaccine thinner without loss of efficacy.
However, as new variants continue to emerge,…
-
General15 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General16 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
General15 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News20 hours agoBrisbane rising on global rankings, but still behind southern capitals